{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:43:13Z","timestamp":1762875793380},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.cmi.2016.03.031","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T03:08:25Z","timestamp":1460257705000},"page":"507-512","source":"Crossref","is-referenced-by-count":14,"title":["Randomized controlled clinical trial on the efficacy of fosfomycin trometamol for uncomplicated gonococcal urethritis in men"],"prefix":"10.1016","volume":"22","author":[{"given":"Z.","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2016.03.031_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.cmi.2016.03.031_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/OLQ.0b013e318285c6d2","article-title":"The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008","volume":"40","author":"Owusu-Edusei","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"RR-03","key":"10.1016\/j.cmi.2016.03.031_bib3","first-page":"1","article-title":"Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cmi.2016.03.031_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of untreatable gonococcal infection","volume":"366","author":"Bolan","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2016.03.031_bib5","article-title":"An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England","author":"Chisholm","year":"2015","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.cmi.2016.03.031_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijantimicag.2015.05.007","article-title":"Neisseria gonorrhoeae and fosfomycin: past, present and future","volume":"46","author":"Tesh","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"3901","key":"10.1016\/j.cmi.2016.03.031_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1126\/science.166.3901.122","article-title":"Phosphonomycin, a new antibiotic produced by strains of streptomyces","volume":"166","author":"Hendlin","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.cmi.2016.03.031_bib8","series-title":"Antimicrobial agents","first-page":"972","article-title":"Fosfomycin and derivatives","author":"Bergogne-B\u00e9r\u00e9zin","year":"2005"},{"key":"10.1016\/j.cmi.2016.03.031_bib9","first-page":"343","article-title":"Acute gonococcal urethritis: failure of response to phosphonomycin therapy","volume":"9","author":"Southern","year":"1969","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"key":"10.1016\/j.cmi.2016.03.031_bib10","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin","volume":"15","author":"Michalopoulos","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2016.03.031_bib11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1128\/AAC.04536-14","article-title":"In\u00a0vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates","volume":"59","author":"Hauser","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2016.03.031_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/phar.1434","article-title":"Fosfomycin for the treatment of resistant Gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists","volume":"34","author":"Reffert","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cmi.2016.03.031_bib13","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/527442","article-title":"Fosfomycin: use beyond urinary tract and gastrointestinal infection","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2016.03.031_bib14","series-title":"Clinical breakpoints, version 4.0","author":"EUCAST","year":"2014"},{"key":"10.1016\/j.cmi.2016.03.031_bib15","series-title":"Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100\u2013S24","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.cmi.2016.03.031_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000222055","article-title":"Bacteriological evaluation of fosfomycin in clinical studies","volume":"23","author":"Rodr\u00edguez","year":"1977","journal-title":"Chemotherapy"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.cmi.2016.03.031_bib17","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1007\/BF01643431","article-title":"Fosfomycin trometamol versus ofloxacin\/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study","volume":"18","author":"Naber","year":"1990","journal-title":"Infection"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16300490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16300490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T13:53:37Z","timestamp":1536846817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X16300490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1198743X16300490"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2016.03.031","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}